These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1259 related items for PubMed ID: 30862474

  • 1. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H, Xie T, Li D, Du X, Wang T, Li C, Song X, Xu L, Yi F, Liang X, Gao L, Yang X, Ma C.
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [Abstract] [Full Text] [Related]

  • 2. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q, Pan J, Zhou ZL, Yin F, Xie HY, Chen PP, Li JY, Zheng PQ, Zhou L, Zhang W, Liu J, Lu LM.
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hirudin Protects Against Kidney Damage in Streptozotocin-Induced Diabetic Nephropathy Rats by Inhibiting Inflammation via P38 MAPK/NF-κB Pathway.
    Han J, Pang X, Zhang Y, Peng Z, Shi X, Xing Y.
    Drug Des Devel Ther; 2020 Jun; 14():3223-3234. PubMed ID: 32848363
    [Abstract] [Full Text] [Related]

  • 5. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F, Sheng XX, Zhang HJ.
    Biochem Biophys Res Commun; 2019 Jul 30; 515(3):410-416. PubMed ID: 31155289
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F, Chen H, Xie Y, Azeloglu EU, Wei C, Zhang W, Li Z, Chuang PY, Jim B, Li H, Elmastour F, Riyad JM, Weber T, Chen H, Wang Y, Zhang A, Jia W, Lee K, He JC.
    J Am Soc Nephrol; 2018 May 30; 29(5):1397-1410. PubMed ID: 29511111
    [Abstract] [Full Text] [Related]

  • 8. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M, Yanjiao D, Shuo W, Kun S, Yanjie L, Mengmeng L.
    Biochem Biophys Res Commun; 2021 Mar 19; 545():46-53. PubMed ID: 33545631
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Integrated network pharmacology and pharmacological investigations to discover the active compounds of Toona sinensis pericarps against diabetic nephropathy.
    Li H, Wang R, Chen Y, Zhao M, Lan S, Zhao C, Li X, Li W.
    J Ethnopharmacol; 2024 Oct 28; 333():118441. PubMed ID: 38851471
    [Abstract] [Full Text] [Related]

  • 11. Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications.
    Noh H, Yu MR, Kim HJ, Lee JH, Park BW, Wu IH, Matsumoto M, King GL.
    Kidney Int; 2017 Jul 28; 92(1):101-113. PubMed ID: 28396116
    [Abstract] [Full Text] [Related]

  • 12. Circ-0000953 deficiency exacerbates podocyte injury and autophagy disorder by targeting Mir665-3p-Atg4b in diabetic nephropathy.
    Liu X, Jiang L, Zeng H, Gao L, Guo S, Chen C, Liu X, Zhang M, Ma L, Li Y, Qi X, Wu Y.
    Autophagy; 2024 May 28; 20(5):1072-1097. PubMed ID: 38050963
    [Abstract] [Full Text] [Related]

  • 13. PTPN14 deficiency alleviates podocyte injury through suppressing inflammation and fibrosis by targeting TRIP6 in diabetic nephropathy.
    Lin Y, Shao Z, Zhao M, Li J, Xu X.
    Biochem Biophys Res Commun; 2021 Apr 23; 550():62-69. PubMed ID: 33684622
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diosmetin Attenuates Akt Signaling Pathway by Modulating Nuclear Factor Kappa-Light-Chain-Enhancer of Activated B Cells (NF-κB)/Inducible Nitric Oxide Synthase (iNOS) in Streptozotocin (STZ)-Induced Diabetic Nephropathy Mice.
    Jiang Y, Liu J, Zhou Z, Liu K, Liu C.
    Med Sci Monit; 2018 Oct 02; 24():7007-7014. PubMed ID: 30278036
    [Abstract] [Full Text] [Related]

  • 16. Calycosin Ameliorates Diabetes-Induced Renal Inflammation via the NF-κB Pathway In Vitro and In Vivo.
    Zhang YY, Tan RZ, Zhang XQ, Yu Y, Yu C.
    Med Sci Monit; 2019 Mar 04; 25():1671-1678. PubMed ID: 30830898
    [Abstract] [Full Text] [Related]

  • 17. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
    Zhang LN, Xie XS, Zuo C, Fan JM.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May 04; 40(3):466-71. PubMed ID: 19627007
    [Abstract] [Full Text] [Related]

  • 18. NLRC5 deficiency ameliorates diabetic nephropathy through alleviating inflammation.
    Luan P, Zhuang J, Zou J, Li H, Shuai P, Xu X, Zhao Y, Kou W, Ji S, Peng A, Xu Y, Su Q, Jian W, Peng W.
    FASEB J; 2018 Feb 04; 32(2):1070-1084. PubMed ID: 29070585
    [Abstract] [Full Text] [Related]

  • 19. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F, Bellini S, Kimura S, Hase K, Corbetta B, Corbelli A, Fiordaliso F, Bruno S, Biancone L, Barreca A, Papotti MG, Hirsh E, Martini M, Gambino R, Durazzo M, Ohno H, Gruden G.
    Autophagy; 2023 Feb 04; 19(2):505-524. PubMed ID: 35659195
    [Abstract] [Full Text] [Related]

  • 20. Astragalus Polysaccharide Ameliorates Renal Inflammatory Responses in a Diabetic Nephropathy by Suppressing the TLR4/NF-κB Pathway.
    Guo M, Gao J, Jiang L, Dai Y.
    Drug Des Devel Ther; 2023 Feb 04; 17():2107-2118. PubMed ID: 37489175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.